Advertisement

Effects of Intensive Diet and Exercise Intervention in Patients Taking Cholesterol-Lowering Drugs

  • R.James Barnard
    Correspondence
    Dr. Barnard, Department of Physiological Science, University of California, Los Angeles, P.O. Box 951527, Los Angeles, California 90095-1527.
    Affiliations
    Department of Physiological Science, University of California, Los AngelesUSA

    Division of Clinical Nutrition, University of California, Los Angeles School of Medicine, Los Angeles, CaliforniaUSA
    Search for articles by this author
  • Steven C. DiLauro
    Affiliations
    Department of Physiological Science, University of California, Los AngelesUSA

    Division of Clinical Nutrition, University of California, Los Angeles School of Medicine, Los Angeles, CaliforniaUSA
    Search for articles by this author
  • Stephen B. Inkeles
    Affiliations
    Department of Physiological Science, University of California, Los AngelesUSA

    Division of Clinical Nutrition, University of California, Los Angeles School of Medicine, Los Angeles, CaliforniaUSA
    Search for articles by this author
      The present study evaluates the effects of an intensive diet and exercise program on serum lipids in patients taking cholesterol-lowering drugs and to ascertain the extent to which the National Cholesterol Education Program (NCEP)[
      Report of the National Cholesterol Education Program Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults.
      ,
      Second report of the Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel II).
      ] dietary guidelines are being used by primary care physicians to lower serum lipids.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. Report of the National Cholesterol Education Program Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults.
        Arch Intern Med. 1988; 148: 36-69
      2. Second report of the Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel II).
        Circulation. 1994; 89: 1330-1344
        • Friedwald WT
        • Levy RI
        • Fredrickson DS
        Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.
        Clin Chem. 1972; 18: 499-502
        • Barnard RJ
        Effects of life-style modification on serum lipids.
        Arch Intern Med. 1991; 151: 1389-1394
        • Barnard RJ
        • Hall JA
        • Chaudhari A
        • Miller JE
        • Kirschenbaum MA
        Effects of low-fat, low-cholesterol diet on serum lipids, platelet aggregation and thromboxane formation.
        Prostaglandins Leukot Med. 1987; 26: 241-252
        • Barnard RJ
        • Pritikin R
        • Rosenthal MB
        • Inkeles S
        Pritikin approach to cardiac rehabilitation.
        in: Goodgold J Rehabilitation Medicine. CV Mosby, St. Louis, MO1988: 267-284
        • Bradford RH
        • Shear CL
        • Chremos AN
        • Dujovne C
        • Downton M
        • Franklin FA
        • Gould LA
        • Hesney M
        • Higgins J
        • Hurley DP
        • Langendorfer A
        • Nash DT
        • Pool JL
        • Schnaper H
        Expanded clinical evaluation of lovastatin (EXCEL) Study results: III. Efficacy in modifying lipoproteins and implications for managing patients with moderate hypercholesterolemia.
        Am J Med. 1991; 91: 1B-24S
        • Lovastatin Study Groups I through IV
        Lovastatin 5-year safety and efficacy study.
        Arch Intern Med. 1993; 153: 1079-1087
        • The Pravastatin Multinational Study Group for Cardiac Risk Patients
        Effects of pravastatin in patients with serum total cholesterol levels from 5.2 to 7.8 mmol/liter (200 to 300 mg/dl) plus two additional atherosclerotic risk factors.
        Am J Cardiol. 1993; 72: 1031-1037
        • Hunninghake DB
        • Stein EA
        • Dujovne CA
        • Harris WS
        • Feldman EB
        • Miller VT
        • Tobert JA
        • Laskarzewski PM
        • Quiter E
        • Held J
        • Taylor AM
        • Hopper S
        • Leonard SB
        • Brewer BK
        The efficacy of intensive dietary therapy alone or combined with lovastatin in outpatients with hypercholesterolemia.
        N Engl J Med. 1993; 328: 1213-1219
        • Stein EA
        • Laskarzewski PM
        Diet-lovastatin interaction on lipid levels.
        Arteriosclerosis. 1990; 10: 786a
        • Clifton PM
        • Wight MB
        • Nestle PJ
        Is fat restriction needed with HMG-CoA reductase inhibitor treatment.
        Atherosclerosis. 1992; 93: 59-70
        • Cobb MM
        • Teitelbaum HS
        • Breslow JL
        Lovastatin efficacy in reducing low-density lipoprotein cholesterol levels on high- vs low-fat diets.
        JAMA. 1991; 265: 997-1001
        • Chisholm A
        • Mann J
        • Sutherland W
        • Williams S
        • Ball M
        Dietary management of patients with familial hypercholesterolemia treated with Simvastatin.
        Q J Med. 1992; 307/308: 825-831
        • Scandinavian Simvastatin Survival Study Group
        Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S).
        Lancet. 1994; 344: 1383-1389